- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- 2025-07-10, 19:22:46
- Local Time:
- 2025-07-16, 16:59:38
- Last Active:
- 2025-07-10, 21:50:23
Signature:
Blinatumomab is a valuable bridging salvage therapy for relapsed or refractory patients to a second or even third HSCT.Despite heavy pretreatment of